ESTUTC-5 New YorkLog in Sign up

SRPT
Sarepta Therapeutics,, Inc. Common Stock
stockNASDAQ

At CloseOct 30, 2026 4:33:30 PM EDT

18.80USD-2.236%(-0.43)1,318,156

Pre-marketOct 30, 2026 10:29:58 AM EDT

18.68USD-2.860%(-0.55)

SRPT News

Day breaks

03:52 PM EDTFDA draft guidance aims to speed personalized gene therapies for rare diseases ·

Seeking Alpha

04:30 PM EDTSarepta Therapeutics to Present at Upcoming Investor Conferences ·

Business Wire

08:30 AM EDTSarepta Therapeutics to Announce Third Quarter 2026 Financial Results ·

Business Wire

01:16 PM EDTFDA unveils rare disease initiative to enhance therapy development ·

Seeking Alpha

01:26 PM EDTSarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT ·

Business Wire

02:13 PM EDTJefferies reiterates Sarepta Therapeutics stock rating on pipeline potential ·

Investing.com

02:57 PM EDTFDA, Duke-Margolis workshop to examine evidence standards for rare diseases ·

Seeking Alpha

12:15 PM EDTSolid Biosciences wins new Outperform at RBC on DMD opportunity ·

Seeking Alpha

05:58 AM EDTOligonucleotide Therapeutics Market Outlook 2026-2035 - Featuring Profiles of Alnylam Pharmaceuticals, Ionis Pharmaceuticals, and Sarepta Therapeutics ·

GlobeNewswire Inc.